最近报道,国家“十二五”重大新药创新专项计划“H型高血压比较效果学研究”项目,率先在江西省正式启动。省内多家医疗机构将在门诊和住院部同时筛查H型高血压。确诊H型高血压者将会受到专业医护人员定期、长期跟踪随访病情发展,并可获得一半的 Recently reported that the state “Twelve-Five ” major new drug innovation special program “H-type hypertension comparative effect research ” project, the first in Jiangxi Province officially started. A number of medical institutions in the province will be in the outpatient and inpatient department at the same time screening for H-type hypertension. Confirmed H-type hypertension will be regular medical professionals, follow-up long-term follow-up of the disease and obtain half